Isaguliants MG - Search Results

1

An overview of "Chronic viral infection and cancer, openings for vaccines" virtual symposium of the TechVac Network - December 16-17, 2021.

Isaguliants MG, Trotsenko I, Buonaguro FM. Isaguliants MG, et al. Infect Agent Cancer. 2022 Jul 8;17(Suppl 2):28. doi: 10.1186/s13027-022-00436-0. Infect Agent Cancer. 2022. PMID: 35804391 Free PMC article.

2

Genetic instability and anti-HPV immune response as drivers of infertility associated with HPV infection.

Isaguliants M, Krasnyak S, Smirnova O, Colonna V, Apolikhin O, Buonaguro FM. Isaguliants M, et al. Infect Agent Cancer. 2021 May 10;16(1):29. doi: 10.1186/s13027-021-00368-1. Infect Agent Cancer. 2021. PMID: 33971936 Free PMC article. Review.

3

The Molecular Interplay between Human Oncoviruses and Telomerase in Cancer Development.

Tornesello ML, Cerasuolo A, Starita N, Tornesello AL, Bonelli P, Tuccillo FM, Buonaguro L, Isaguliants MG, Buonaguro FM. Tornesello ML, et al. Among authors: isaguliants mg. Cancers (Basel). 2022 Oct 26;14(21):5257. doi: 10.3390/cancers14215257. Cancers (Basel). 2022. PMID: 36358677 Free PMC article. Review.

4

Proceedings of the Online Conference "Vaccines and Vaccination during and Post COVID Pandemics" (7-9 December 2022).

Sokolovska L, Isaguliants M, Buonaguro FM. Sokolovska L, et al. Vaccines (Basel). 2023 Jun 29;11(7):1175. doi: 10.3390/vaccines11071175. Vaccines (Basel). 2023. PMID: 37514990 Free PMC article.

5

Chronic Viral Infections and Cancer, Openings for Therapies and Vaccines.

Isaguliants MG, Ivanov AV, Buonaguro FM. Isaguliants MG, et al. Cancers (Basel). 2024 Feb 18;16(4):818. doi: 10.3390/cancers16040818. Cancers (Basel). 2024. PMID: 38398209 Free PMC article.

6

Perspective Technologies of Vaccination: Do We Still Need Old Vaccines?

Isaguliants M, Burt FJ. Isaguliants M, et al. Vaccines (Basel). 2022 Jun 2;10(6):891. doi: 10.3390/vaccines10060891. Vaccines (Basel). 2022. PMID: 35746498 Free PMC article.

7

Carcinogenesis Associated with Human Papillomavirus Infection. Mechanisms and Potential for Immunotherapy.

Vonsky M, Shabaeva M, Runov A, Lebedeva N, Chowdhury S, Palefsky JM, Isaguliants M. Vonsky M, et al. Biochemistry (Mosc). 2019 Jul;84(7):782-799. doi: 10.1134/S0006297919070095. Biochemistry (Mosc). 2019. PMID: 31509729 Review.

8

Therapeutic Vaccines Against Human Papilloma Viruses: Achievements and Prospects.

Vonsky MS, Runov AL, Gordeychuk IV, Isaguliants MG. Vonsky MS, et al. Among authors: isaguliants mg. Biochemistry (Mosc). 2019 Jul;84(7):800-816. doi: 10.1134/S0006297919070101. Biochemistry (Mosc). 2019. PMID: 31509730 Review.

9

Oncogenic Effects of HIV-1 Proteins, Mechanisms Behind.

Isaguliants M, Bayurova E, Avdoshina D, Kondrashova A, Chiodi F, Palefsky JM. Isaguliants M, et al. Cancers (Basel). 2021 Jan 15;13(2):305. doi: 10.3390/cancers13020305. Cancers (Basel). 2021. PMID: 33467638 Free PMC article. Review.

10

Prevalence and Risk Factors of Infection with High Risk Human Papilloma Viruses among HIV-Positive Women with Clinical Manifestations of Tuberculosis in a Middle-Income Country.

Isaguliants M, Nosik M, Karlsen A, Petrakova N, Enaeva M, Lebedeva N, Podchufarova D, Laga V, Gromov K, Nazarov A, Chowdhury S, Sinitsyn M, Sobkin A, Chistyakova N, Aleshina S, Grabarnik A, Palefsky JM. Isaguliants M, et al. Biomedicines. 2021 Jun 16;9(6):683. doi: 10.3390/biomedicines9060683. Biomedicines. 2021. PMID: 34208764 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

105 results

Search Page